首页> 外国专利> compound, pharmaceutical composition, ikkb inhibitor, method for inhibiting ikkb, methods for preventing and / or treating a disease or symptom associated with nf-kb, a disease or symptom associated with ikkb, and a disease or symptom associated with acute or inflammatory reaction. chronic in mammals

compound, pharmaceutical composition, ikkb inhibitor, method for inhibiting ikkb, methods for preventing and / or treating a disease or symptom associated with nf-kb, a disease or symptom associated with ikkb, and a disease or symptom associated with acute or inflammatory reaction. chronic in mammals

机译:化合物,药物组合物,ikkb抑制剂,抑制ik​​kb的方法,预防和/或治疗与nf-kb相关的疾病或症状,与ikkb相关的疾病或症状,以及与急性或炎性反应相关的疾病或症状的方法。哺乳动物慢性

摘要

The present invention relates to a compound represented by the following formula (1): wherein D 1 , A 1 , D 2 , R 1 , D 3 , and R 2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKK² inhibiting activity and the like and is useful for the prevention and/or treatment of IKK²-associated diseases or symptoms and the like.
机译:本发明涉及由下式(1)表示的化合物:其中D 1,A 1,D 2,R 1,D 3和R 2各自具有与本说明书或其盐相同的含义。式(1)表示的化合物或其盐具有抑制IKK 2的活性等,可用于预防和/或治疗与IKK 2有关的疾病或症状等。

著录项

  • 公开/公告号BRPI0919282A2

    专利类型

  • 公开/公告日2017-03-28

    原文格式PDF

  • 申请/专利权人 ASAHI KASEI PHARMA CORPORATION;

    申请/专利号BR2009PI19282

  • 申请日2009-10-01

  • 分类号C07D217/02;A61K31/472;A61K31/4725;A61K31/496;A61K31/501;A61K31/5377;A61P3/10;A61P9;A61P9/10;A61P17/04;A61P17/06;A61P19;A61P19/10;A61P29;A61P35;A61P37;A61P37/06;A61P37/08;A61P43;C07D401/12;C07D401/14;C07D405/14;C07D409/04;C07D409/14;C07D413/14;C07D417/14;C07D471/04;

  • 国家 BR

  • 入库时间 2022-08-21 13:39:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号